Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/4487Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bottomley, A. | - |
| dc.contributor.author | Thomas, R. | - |
| dc.contributor.author | VAN STEEN, Kristel | - |
| dc.contributor.author | Flechtner, H. | - |
| dc.date.accessioned | 2007-12-20T15:49:52Z | - |
| dc.date.available | 2007-12-20T15:49:52Z | - |
| dc.date.issued | 2002 | - |
| dc.identifier.citation | The lancet oncology, 3(3). p. 145-153 | - |
| dc.identifier.issn | 1470-2045 | - |
| dc.identifier.uri | http://hdl.handle.net/1942/4487 | - |
| dc.language.iso | en | - |
| dc.publisher | Lancet LTD | - |
| dc.title | Human recombinant erythroprotein and quality of life: a wonder drug or soemthing to wonder about? | - |
| dc.type | Journal Contribution | - |
| dc.identifier.epage | 153 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.spage | 145 | - |
| dc.identifier.volume | 3 | - |
| local.bibliographicCitation.jcat | A1 | - |
| local.type.refereed | Refereed | - |
| local.type.specified | Article | - |
| dc.bibliographicCitation.oldjcat | A1 | - |
| dc.identifier.doi | 10.1016/S1470-2045(02)00677-0 | - |
| dc.identifier.isi | 000174890300018 | - |
| item.contributor | Bottomley, A. | - |
| item.contributor | Thomas, R. | - |
| item.contributor | VAN STEEN, Kristel | - |
| item.contributor | Flechtner, H. | - |
| item.accessRights | Closed Access | - |
| item.fulltext | No Fulltext | - |
| item.fullcitation | Bottomley, A.; Thomas, R.; VAN STEEN, Kristel & Flechtner, H. (2002) Human recombinant erythroprotein and quality of life: a wonder drug or soemthing to wonder about?. In: The lancet oncology, 3(3). p. 145-153. | - |
| crisitem.journal.issn | 1470-2045 | - |
| crisitem.journal.eissn | 1474-5488 | - |
| Appears in Collections: | Research publications | |
SCOPUSTM
Citations
50
checked on Aug 12, 2026
WEB OF SCIENCETM
Citations
38
checked on Aug 16, 2026
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.